SCHEMBL11303328

SCHEMBL11303328

O=C(NO)c1ccc(N(c2cc(Cl)cc(Cl)c2)C2CCNC2=O)cc1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ HDAC8 Q9BY41 8/20 0.37
▸ PSEN1 P49768 6/20 0.37
▸ PSEN2 P49810 6/20 0.37
▸ APH1B Q8WW43 6/20 0.37
▸ NCSTN Q92542 6/20 0.37
▸ APH1A Q96BI3 6/20 0.37
▸ PSENEN Q9NZ42 6/20 0.37
▸ HDAC6 Q9UBN7 7/20 0.36
▸ HDAC1 Q13547 5/20 0.35
▸ ENPP2 Q13822 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ ALOX15 P16050 1/20 0.35
▸ ALOX12 P18054 1/20 0.35
▸ RECQL P46063 1/20 0.35
▸ ADAM17 P78536 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ RAB9A P51151 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11300698 0.92 PSEN1 (0.36) HDAC8PSEN1PSEN2APH1BNCSTN
SCHEMBL11301754 0.92 PSEN1 (0.42) HDAC8PSEN1PSEN2APH1BNCSTN
SCHEMBL11298752 0.90 HDAC8 (0.42) HDAC8PSEN1PSEN2APH1BNCSTN
SCHEMBL11296595 0.87 HDAC6 (0.42) HDAC8PSEN1PSEN2APH1BNCSTN
SCHEMBL11303268 0.87 ABL1 (0.37) HDAC8PSEN1PSEN2APH1BNCSTN
SCHEMBL11304464 0.84 HDAC8 (0.37) HDAC8PSEN1PSEN2APH1BNCSTN
SCHEMBL11305647 0.84 HDAC6 (0.41) HDAC8HDAC6HDAC1KDM4EMEN1
SCHEMBL11299083 0.84 HDAC6 (0.42) HDAC8PSEN1PSEN2APH1BNCSTN
SCHEMBL11301770 0.84 PSEN1 (0.38) HDAC8PSEN1PSEN2APH1BNCSTN
SCHEMBL11297375 0.83 HDAC8 (0.44) HDAC8HDAC6HDAC1KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP claimed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO claimed
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP disclosed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO disclosed
Send feedback